Results 151 to 160 of about 3,110,326 (313)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

The Faithful and the Reasonable Chapters on ecological Foolishness

open access: yes
Intro -- Contents -- Foreword -- I. Introduction: Creatures are dying, but we have our own worries -- II. Some interpretative keys -- II.1. Universal key:(UK) faithfulness, compassion, responsibility -- Faithfulness to the nest -- II.2.
Galčanová, Lucie.   +3 more
core  

Dutch infants’ sensitivity to lexical tones under perceptual reorganization : a cross-sectional study

open access: yes, 2011
Previous studies show that infants undergo a perceptual reorganization (PR) in their sensitivity to lexical tones between 6 and 9 months in the first year of life [Mattock & Burnham, 1; Mattock, Molnar, Polka & Burnham, 2].
Kager, René, Liu, Liquan (R18335)
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Impact of IPSAS Compliance on Faithful Representation of Financial Reporting by State Governments in Northern Nigeria

open access: yes
This study examines the impact of International Public Sector Accounting Standards (IPSAS) compliance on faithful representation of financial reporting by state governments in northern Nigeria.
Kefas James TAGWI
core   +1 more source

Faithful to the context? The presentation and representation of American objects in European collections

open access: yesAnuário Antropológico, 2018
In an exhibition entitled ART/artifact, which could be seen in various US museums between 1988 and 1990, objects from Africa were displayed in a variety of museum settings and installation styles (Exhibition Catalogue New York 1988).
Peter Mason
doaj  

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy